JP5141881B2 - Intranasal medication device - Google Patents

Intranasal medication device Download PDF

Info

Publication number
JP5141881B2
JP5141881B2 JP2007331207A JP2007331207A JP5141881B2 JP 5141881 B2 JP5141881 B2 JP 5141881B2 JP 2007331207 A JP2007331207 A JP 2007331207A JP 2007331207 A JP2007331207 A JP 2007331207A JP 5141881 B2 JP5141881 B2 JP 5141881B2
Authority
JP
Japan
Prior art keywords
capsule
air
intranasal
piercing member
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2007331207A
Other languages
Japanese (ja)
Other versions
JP2009148506A (en
Inventor
昇 中島
光輝 藤原
雅光 中里
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Priority to JP2007331207A priority Critical patent/JP5141881B2/en
Publication of JP2009148506A publication Critical patent/JP2009148506A/en
Application granted granted Critical
Publication of JP5141881B2 publication Critical patent/JP5141881B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

本発明は、カプセルに封入された粉末状又は液体状の薬剤を鼻腔内に投与するために用いられる鼻腔内投薬装置に関するものである。   The present invention relates to an intranasal administration device used for intranasal administration of a powdery or liquid drug encapsulated in a capsule.

鼻炎や鼻アレルギー等の疾患を持つ患者に対して、カプセル内に封入した薬剤を鼻腔内に噴霧して投与する専用の投薬装置が用いられている。   For patients with diseases such as rhinitis and nasal allergies, dedicated medication devices are used that spray and administer drugs encapsulated in capsules into the nasal cavity.

従来の鼻腔内投薬装置としては、粉末状の薬剤を封入したカプセルを収納するカプセル収容室を、薬剤の噴出ノズルとカプセル収容室に空気を供給するための押圧ポンプとの間に配置し、カプセルの一端側及び他端側に薬剤の噴出口と給気口をピンや刃物により穿孔し、ポンプを押圧することでカプセル内に空気を圧入して噴出口から薬剤を噴出させる構成とされたものが知られている(例えば、特許文献1、許文献2及び特許文献3参照。)。   As a conventional intranasal administration device, a capsule storage chamber for storing a capsule encapsulating a powdered drug is disposed between a spray nozzle for the drug and a pressure pump for supplying air to the capsule storage chamber. The drug outlet and air supply port are drilled with pins or blades at one end and the other end of the tube, and the pump is pressed to inject air into the capsule and eject the drug from the nozzle Is known (see, for example, Patent Document 1, Permitted Document 2, and Patent Document 3).

特許第2881605号公報Japanese Patent No. 2881605 特許第3308425号公報Japanese Patent No. 3308425 特開2004―129823号公報JP 2004-129823 A

特許文献1に記載された投薬装置においては、粉末状の薬剤を封入したカプセルをカプセル収容室に装填した後、キャップの着脱によりキャップ内に設けた長針により、カプセルに上部流出穴及び下部流入穴を噴出軸方向に貫通開口させる構成とされている。?また、特許文献2においては、カプセルをカプセルホルダーに装填すると同時に、カプセルホルダーに設けた第1の穴あけピンで、カプセルの下部に空気流入口を穿孔し、薬品噴霧部を接合すると同時に第1の穴あけピンが自動的に抜去され、薬品噴霧部に設けられた移動式の第2の穴あけピンを往復移動することにより、薬品の流出穴を開口する装置が開示されている。   In the dosing device described in Patent Document 1, after loading a capsule containing a powdered medicine into a capsule storage chamber, an upper outflow hole and a lower inflow hole are formed in the capsule by a long needle provided in the cap by attaching and detaching the cap. It is set as the structure which makes a through-opening in the ejection axis direction. In Patent Document 2, the capsule is loaded into the capsule holder, and at the same time, the first perforation pin provided in the capsule holder is used to pierce the air inlet at the lower part of the capsule and join the chemical spraying portion. A device for opening a medicine outflow hole by reciprocating a movable second drilling pin provided in a medicine spraying section is disclosed.

特許文献3においては、薬剤の噴霧部と、押圧ポンプ部の間に配置されるカプセル収容部を有し、カプセル収容部は引き出し状のカプセル入出部とカプセル収容保持部とから構成され、カプセルをカプセル入出部に装着し、カプセル収容保持部に押し込むことで、カプセルの上下端に薬剤流出口と空気の流入口をカッター様の刃具で切削開口する構成とされている。   In patent document 3, it has a capsule accommodating part arrange | positioned between the spray part of a chemical | medical agent, and a press pump part, and a capsule accommodating part is comprised from the drawer-like capsule insertion / extraction part and the capsule accommodation holding | maintenance part, The medicine outlet and the air inlet are cut and opened by a cutter-like cutting tool at the upper and lower ends of the capsule by being attached to the capsule inlet / outlet and being pushed into the capsule housing / holding part.

しかしながら、上記いずれの装置においても、カプセルの一端側に空気の噴入口、カプセルの他端側に薬剤の噴出口を形成するものであり、特にカプセルに噴入口を形成する際に、開口と同時にカプセル内から薬剤が漏れ出し、空気の流通経路に堆積することが原因で噴出不足を起こすおそれがある。すなわち、堆積した薬剤により押圧ポンプからの通気路が塞がれ、一回の押圧操作でカプセル内の薬剤を全量噴出するために十分な量の空気を供給することができなくなり、必要量の投薬をするのに手間がかかるという問題が発生する。したがって、装置内を頻繁に清掃する必要があり使い勝手が悪い。また、特許文献1及び特許文献2に記載された装置においては、投薬までに、カプセルの装填、ノズルの接合、穴あけ具の刺抜という少なくとも4行程の操作を要し手間がかかる。
本発明は、上記のような従来技術の課題に鑑みなされたもので、薬剤の噴出準備が一手順で整い、カプセルから漏れ出した薬剤の堆積によって、押圧ポンプからの通気路が閉塞することを防止し、投薬準備操作が簡便になり、常に適切な量の薬剤を安定して投与することができる鼻腔内投薬装置を提供することを目的とする。
However, in any of the above-described devices, an air injection port is formed on one end side of the capsule, and a drug injection port is formed on the other end side of the capsule. There is a possibility that the medicine leaks out from the capsule and accumulates in the air flow path, resulting in insufficient ejection. In other words, the accumulated medicine blocks the air passage from the pressure pump, and it becomes impossible to supply a sufficient amount of air to eject the entire amount of medicine in the capsule by a single pressing operation. There is a problem that it takes time and effort. Therefore, it is necessary to frequently clean the inside of the apparatus, which is inconvenient. In addition, the devices described in Patent Document 1 and Patent Document 2 require operations of at least four steps of loading a capsule, joining a nozzle, and piercing a drilling tool before dosing.
The present invention has been made in view of the problems of the prior art as described above, and preparation of a medicine ejection is completed in one procedure, and accumulation of medicine leaking from the capsule causes the air passage from the pressure pump to be blocked. An object of the present invention is to provide an intranasal dosing device capable of preventing, making a dosing preparation operation simple, and always stably administering an appropriate amount of drug.

そこで、本発明による鼻腔内投薬装置は、鼻腔内に挿入可能に形成された噴出ノズルと、粉末状又は液体状の薬剤が封入されたカプセルが装填されるカプセル収容部と、該カプセル収納部に連通されると共に、カプセル内に空気を噴気する押圧ポンプ部と、前記カプセル内に空気が出入り可能な給排気孔を形成する穿孔部材とを備え、請求項1記載の発明の特徴は、前記噴出ノズル側のみに前記穿孔部材を設けると共に、押圧ポンプ部から送気される空気を噴出ノズル側のみに流通させる通気路を設け、前記穿孔部材が、管状に形成されると共に、その先端部管径が軸部管径よりも大に形成されていることにある。 Therefore, an intranasal administration device according to the present invention includes an ejection nozzle formed so as to be insertable into the nasal cavity, a capsule housing portion in which a capsule in which a powdery or liquid medicine is sealed, and a capsule housing portion. The invention according to claim 1, further comprising: a pressure pump unit that communicates and blows air into the capsule; and a perforating member that forms an air supply / exhaust hole through which air can enter and exit the capsule. provided with the piercing member only on the nozzle side, the air passage for circulating the air that is blown from the pressing pump unit only ejection nozzle side is provided, wherein the piercing member is is formed in a tubular, the tip tube diameter Is formed to be larger than the shaft tube diameter .

請求項2記載の発明の特徴は、請求項1記載の鼻腔内投薬装置において、穿孔部材を、カプセルへの空気流入口と薬剤が噴出される薬剤噴出口が単一の孔になるように形成可能に構成したこと特徴とする。   According to a second aspect of the present invention, in the intranasal administration device according to the first aspect, the piercing member is formed so that the air inlet to the capsule and the drug outlet from which the drug is jetted are formed as a single hole. It is characterized by being configured.

請求項記載の発明の特徴は、請求項1又は請求項2記載の鼻腔内投薬装置において、穿孔部材が、内管と外管の二重のコアキシャル様に形成されていることを特徴とする。 According to a third aspect of the present invention, in the intranasal administration device according to the first or second aspect, the piercing member is formed in a double coaxial manner of the inner tube and the outer tube. .

請求項記載の発明の特徴は、請求項1又は請求項2記載の鼻腔内投薬装置において、穿孔部材の内部が、二本の通路(ダブルルーメン様)に区画形成されていることを特徴とする。 According to a fourth aspect of the present invention, in the intranasal administration device according to the first or second aspect, the inside of the piercing member is partitioned into two passages (double lumen-like). To do.

請求項記載の発明の特徴は、請求項1又は請求項2記載の鼻腔内投薬装置において、穿孔部材の外側面に、空気の噴出方向に倣って溝条が形成されていることを特徴とする。 According to a fifth aspect of the present invention, in the intranasal administration device according to the first or second aspect, a groove is formed on the outer surface of the piercing member so as to follow the air ejection direction. To do.

請求項記載の発明の特徴は、請求項1記載の鼻腔内投薬装置において、穿孔部材が少なくとも二本の管体から構成されていることを特徴とする According to a sixth aspect of the present invention, in the intranasal administration device according to the first aspect, the piercing member is composed of at least two tubes .

請求項記載の発明の特徴は、請求項1記載の鼻腔内投薬装置において、穿孔部材が少なくとも一本の棒体と一本の管体から構成され、棒体の先端部径が軸部径よりも大に形成されていることを特徴とする。



According to a seventh aspect of the present invention, in the intranasal administration device according to the first aspect, the perforating member is composed of at least one rod body and one tube body, and the distal end diameter of the rod body is a shaft portion diameter. It is characterized by being formed larger than.



尚、本発明によるとカプセル内に収容される薬剤は、粉末状又は液状でも使用することが可能で、粉末状薬剤に限定されるものではない。   According to the present invention, the drug contained in the capsule can be used in powder or liquid form, and is not limited to powder drug.

本発明は、以下の優れた効果がある。
(1)薬剤が封入されたカプセルに、薬剤が噴出する方向にのみに開口を穿孔するようにしたので、カプセル内から漏れ出した粉薬の堆積によって、通気路が閉塞することを防止し、常に適量の薬を安定して投与することができる。
(2)カプセル内の薬剤を無駄なく効率よく鼻腔内に噴出することができる。
(3)通気路に薬剤が堆積することがなく、装置内部を頻繁に清掃する手間がなくなる。
(4)鼻水などにより通気口が閉塞されて薬剤の噴出に支障をきたすおそれがなくなる。
(5)投薬準備操作が簡便になる。
The present invention has the following excellent effects.
(1) Since the opening is perforated only in the direction in which the medicine is ejected in the capsule in which the medicine is encapsulated, the air passage is prevented from being blocked by the accumulation of powder medicine leaking from the inside of the capsule. An appropriate amount of drug can be stably administered.
(2) The medicine in the capsule can be efficiently ejected into the nasal cavity without waste.
(3) There is no accumulation of chemicals in the ventilation path, and there is no need to frequently clean the inside of the apparatus.
(4) The possibility of obstructing the ejection of the medicine due to the obstruction of the vent due to the runny nose is eliminated.
(5) The medication preparation operation is simplified.

次に、本発明の実施の形態を図面に示す実施例に基づいて説明する。
図1乃至図3は本発明に係る鼻腔内投薬装置の一実施例を示す縦断面図、図4は本発明に係る鼻腔内投薬装置の要部分解斜視図、図5(a)は穿孔部材の他の実施例を示す縦断面図、(b)は横断面図、図6(a)は穿孔部材の他の実施例を示す縦断面図、(b)は横断面図、図7(a)は穿孔部材の他の実施例を示す縦断面図、(b)は横断面図、図8(a)は穿孔針の他の実施例を示す縦断面図、(b)は横断面図、図9は穿孔パターンを示す要部縦断面図、図10は押圧ポンプ部の他の実施例を示す縦断面図、図11は押圧ポンプ部及び噴出ノズルの他の実施例を示す縦断面図である。
Next, embodiments of the present invention will be described based on examples shown in the drawings.
1 to 3 are longitudinal sectional views showing an embodiment of an intranasal medication device according to the present invention, FIG. 4 is an exploded perspective view of a main part of the intranasal medication device according to the present invention, and FIG. FIG. 6A is a longitudinal sectional view showing another embodiment, FIG. 6B is a transverse sectional view, FIG. 6A is a longitudinal sectional view showing another embodiment of the perforated member, FIG. ) Is a longitudinal sectional view showing another embodiment of the piercing member, (b) is a transverse sectional view, FIG. 8 (a) is a longitudinal sectional view showing another embodiment of the piercing needle, (b) is a transverse sectional view, FIG. 9 is a longitudinal sectional view of a main part showing a perforation pattern, FIG. 10 is a longitudinal sectional view showing another embodiment of the press pump section, and FIG. 11 is a longitudinal sectional view showing another embodiment of the press pump section and the ejection nozzle. is there.

図1乃至図4に示すように、本発明に係る鼻腔内投薬装置Sのカプセルホルダー8のカプセル保持部6内には、粉末状の薬剤7が封入されたカプセルKが装填可能にされており、鼻腔に挿入可能に形成された噴出ノズル2が取付けられたキャップ1を、カプセルホルダー8の先端側に連結すると、キャップ1内に設けられた穿孔部材(穿孔針)4が、カプセルKに突き刺さり、給排気孔H1が開設される。ここで、穿孔部材4は、先端の尖った管状に形成されると共に、その先端部4aの管径が軸部4bの管径よりも大に形成されており、カプセルKには、先ず、先端部4aの直径と同じ径の孔H1が開設されるが、キャップ1をさらに押し込むことで、開口した孔H1の辺縁と穿孔部材4の軸管部4bの外側面との間には間隙Z(排気路5b)が形成されることとなる。   As shown in FIGS. 1 to 4, a capsule K in which a powdery medicine 7 is sealed can be loaded in the capsule holding portion 6 of the capsule holder 8 of the intranasal medication device S according to the present invention. When the cap 1 to which the ejection nozzle 2 formed so as to be insertable into the nasal cavity is connected to the distal end side of the capsule holder 8, the piercing member (piercing needle) 4 provided in the cap 1 pierces the capsule K. The air supply / exhaust hole H1 is opened. Here, the perforating member 4 is formed in a tubular shape with a sharp tip, and the tube diameter of the tip portion 4a is formed larger than the tube diameter of the shaft portion 4b. A hole H1 having the same diameter as the diameter of the portion 4a is opened, but when the cap 1 is further pushed in, a gap Z is formed between the edge of the opened hole H1 and the outer surface of the shaft tube portion 4b of the piercing member 4. (Exhaust passage 5b) is formed.

すなわち、本発明装置Sによれば、カプセルKに、押圧ポンプ14から押し出された空気が出入り可能な給排気孔H1が噴出ノズル2側のみに設けられる。また、押圧ポンプ14から送気される空気A1を噴出ノズル2側のみに流通させる通気路5及び8aが、キャップ1並びにカプセルホルダー8に設けられている。   That is, according to the device S of the present invention, the capsule K is provided with the air supply / exhaust hole H1 through which the air pushed out from the pressure pump 14 can enter and exit only on the ejection nozzle 2 side. In addition, the cap 1 and the capsule holder 8 are provided with air passages 5 and 8 a through which the air A <b> 1 supplied from the press pump 14 flows only to the ejection nozzle 2 side.

また、カプセルホルダー8の下端は、押圧ポンプ14に密封状態で嵌合固定される略逆錐形状のスカート部を備えた端部隔壁13を有する筒状の連結部材11で連結されるが、この連結部材11内には、気室11bが形成され、気室11bには両側から外気16を導入するための吸気路12と、押圧ポンプ14の噴気を気室11b内に流通させる空気流入口15と、この噴気をカプセルホルダー8の下端に送気するための通気孔11aが穿孔される。   Further, the lower end of the capsule holder 8 is connected by a cylindrical connecting member 11 having an end partition wall 13 having a substantially inverted cone-shaped skirt portion that is fitted and fixed to the pressure pump 14 in a sealed state. An air chamber 11b is formed in the connecting member 11, an air passage 12 for introducing outside air 16 from both sides of the air chamber 11b, and an air inlet 15 through which the air blown from the pressure pump 14 flows into the air chamber 11b. Then, a vent hole 11 a for feeding this fumarole to the lower end of the capsule holder 8 is drilled.

さらに、気室11b内には、気室11b内を上下動可能な第1可動弁10が収容される。同様にカプセルホルダー8の下端には、下方に開放された凹所8bが形成され、この凹所8bを上下動可能な円板状の第2可動弁9が収容される。ここで、第1可動弁10は周囲に鍔部10bが設けられると共に、その中央に通気孔10aが穿孔される。   Furthermore, the first movable valve 10 that can move up and down in the air chamber 11b is accommodated in the air chamber 11b. Similarly, a recess 8b opened downward is formed at the lower end of the capsule holder 8, and a disc-shaped second movable valve 9 capable of moving up and down the recess 8b is accommodated. Here, the first movable valve 10 is provided with a flange portion 10b around it, and a vent hole 10a is formed in the center thereof.

そして、押圧ポンプ14を押圧し噴気すると、連結部材11の端部隔壁13に着座して空気流通入口15を塞いでいた第1可動弁10が浮上し、気室11bの吸気路12が第1可動弁10の鍔部10bにより閉ざされ、噴気A1は第1可動弁10の通気孔10a及び通気孔11aを通り、第2可動弁9を上方(矢示W1方向)に押し上げると共に、カプセルホルダー8の通気路8aを介して、キャップ1の送気路5に分流し、穿孔部材4内の給気路5aを通って下方(矢示Y1方向)に送気され、カプセルK内に噴気される。これにより、カプセルK内の薬剤7は拡散しながら上方(矢示Y2方向)に舞い上がり、間隙Z(排気路5b)からキャップ1の噴気路3を通って噴出ノズル2から放出され鼻腔内に噴霧される。   When the pressure pump 14 is pressed and blown, the first movable valve 10 sitting on the end partition wall 13 of the connecting member 11 and closing the air flow inlet 15 is lifted, and the air intake path 12 of the air chamber 11b is the first. Closed by the flange 10b of the movable valve 10, the fumarole A1 passes through the vent hole 10a and the vent hole 11a of the first movable valve 10, pushes up the second movable valve 9 upward (in the direction of the arrow W1), and capsule holder 8 The air is divided into the air supply passage 5 of the cap 1 through the air passage 8a, and is supplied downward (in the direction of arrow Y1) through the air supply passage 5a in the piercing member 4, and is injected into the capsule K. . As a result, the drug 7 in the capsule K rises upward (in the direction indicated by arrow Y2) while diffusing, and is discharged from the ejection nozzle 2 through the air passage 3 of the cap 1 from the gap Z (exhaust passage 5b) and sprayed into the nasal cavity. Is done.

ここで、ポンピング操作により狭窄したポンプ14が復元(矢示X2方向)する際、外気を吸入すると同時に第2可動弁9が下方に吸引されることで、通気孔11aが閉ざされ、第1可動弁10が押圧ポンプ14の端部隔壁13に着座し、閉塞されていた吸気路12が再び開口して外気16がポンプ14内に吸引される。   Here, when the pump 14 narrowed by the pumping operation is restored (in the direction of arrow X2), the second movable valve 9 is sucked downward at the same time as the outside air is sucked, whereby the vent hole 11a is closed and the first movable valve is closed. The valve 10 is seated on the end partition wall 13 of the press pump 14, the closed intake passage 12 is opened again, and the outside air 16 is sucked into the pump 14.

以下、本発明に係る鼻腔内投薬装置Sの他の実施例を示すが、便宜上、実施例1と同様の構成要素には同一の参照符号を付して説明する。   Hereinafter, although other examples of intranasal medication device S concerning the present invention are shown, the same referential mark is attached and explained to the same component as Example 1 for convenience.

図5に示すように、カプセルKに給排気孔H1を開口するための穿孔部材4を内管4eと外管4fの二重のコアキシャル様に形成することにより、内管4eと外管4fの間隙(給気路)5aから送気された空気がカプセルK内に流入し、内管4eの排気路5bからカプセルK内の薬剤7が押し出されるように流出する構成、または、図6に示すように、逆に内管4eに給気された空気がカプセルK内に流入し、前記間隙5aからカプセルK内の薬剤7が押し出されるように排出する構成にすることもできる。   As shown in FIG. 5, by forming the punching member 4 for opening the air supply / exhaust hole H1 in the capsule K in a double coaxial manner of the inner tube 4e and the outer tube 4f, the inner tube 4e and the outer tube 4f are formed. FIG. 6 shows a configuration in which the air supplied from the gap (air supply path) 5a flows into the capsule K and flows out so that the medicine 7 in the capsule K is pushed out from the exhaust path 5b of the inner tube 4e. Similarly, the air supplied to the inner tube 4e can flow into the capsule K and be discharged so that the medicine 7 in the capsule K is pushed out from the gap 5a.

図7に示すように、カプセルKに給排気孔H1を開口するための穿孔部材4の内部を、隔壁4dにより、少なくとも二本の通路5a及び5b(ダブルルーメン様)に区画形成することにより、一方の通路5aに送気された空気がカプセルK内に流入し、他方の通路5bから薬剤7を押し出すように流出する構成にすることもできる。   As shown in FIG. 7, by forming the inside of the piercing member 4 for opening the air supply / exhaust hole H1 in the capsule K into at least two passages 5a and 5b (double lumen-like) by the partition wall 4d, It is also possible to adopt a configuration in which the air fed into one passage 5a flows into the capsule K and flows out so as to push out the medicine 7 from the other passage 5b.

図8に示すように、カプセルKに給排気孔H1を開口するための穿孔部材4を、その外側面に空気の噴出方向に倣って溝条4gが形成された単管4e状に形成し、溝条4gにより形成される給気路5aを通って送気された空気がカプセルK内に流入し、単管4eの排気路5bからカプセルK内の薬剤7が押し出されるように流出する構成、又は、逆に単管4e内に送気された空気がカプセルK内に流入し、溝条4gからカプセルK内の薬剤7が押し出されるように流出する構成にすることもできる。   As shown in FIG. 8, the punching member 4 for opening the air supply / exhaust hole H1 in the capsule K is formed in the shape of a single tube 4e in which grooves 4g are formed on the outer surface of the capsule K along the air ejection direction. A configuration in which air sent through the air supply path 5a formed by the groove 4g flows into the capsule K and flows out so that the medicine 7 in the capsule K is pushed out from the exhaust path 5b of the single tube 4e; Or conversely, the air sent into the single tube 4e may flow into the capsule K and flow out so that the medicine 7 in the capsule K is pushed out from the groove 4g.

図9(a)に示すように、カプセルKに給排気孔H1を開口するための穿孔部材4を、少なくとも隣接した二本の管体4e及び4fから構成し、一方の管体4eに送気された空気A1がカプセルK内へ流入し、他方の管体4fからカプセル内の薬剤が空気A2と共に押し出される構成にすることもできる。また、図9(b)に示すように、カプセルKに給排気孔H1を開口するための穿孔部材4を、棒体4hと管体4eから構成し、棒体4hの先端部棒径を軸部棒径より大に形成する。この棒体4hにより、カプセルK内に空気A1が出入り可能な給排気H1が開設されると共に、給排気H1の辺縁と棒体4hの軸部の外側面との間に間隙Zが形成される。そして、管体4eに送気された空気A1がカプセルK内に流入し、間隙ZからカプセルK内の薬剤7が空気A2と共に押し出される構成、又は、図9(c)に示すように、逆に間隙Zに送気された空気A1がカプセルK内に流入し、管体4fからカプセルK内の薬剤7が押し出される構成にすることもできる。   As shown in FIG. 9A, the piercing member 4 for opening the air supply / exhaust hole H1 in the capsule K is composed of at least two adjacent pipe bodies 4e and 4f, and air is supplied to one pipe body 4e. It is also possible to adopt a configuration in which the air A1 thus flowed flows into the capsule K and the medicine in the capsule is pushed out together with the air A2 from the other tube body 4f. Further, as shown in FIG. 9B, the piercing member 4 for opening the air supply / exhaust hole H1 in the capsule K is composed of a rod body 4h and a tube body 4e, and the rod diameter of the tip end portion of the rod body 4h is pivoted. It is formed larger than the part bar diameter. By this rod 4h, an air supply / exhaust H1 through which air A1 can enter and exit the capsule K is established, and a gap Z is formed between the edge of the air supply / exhaust H1 and the outer surface of the shaft portion of the rod 4h. The Then, the air A1 sent to the tube 4e flows into the capsule K, and the medicine 7 in the capsule K is pushed out together with the air A2 from the gap Z, or as shown in FIG. Alternatively, the air A1 fed into the gap Z may flow into the capsule K and the medicine 7 in the capsule K may be pushed out from the tube 4f.

[実験例1]
投薬装置にカプセルを装填し押圧ポンプのポンピング回数により噴出される噴出率を測定した。
本実験では2号サイズ(容量0.37ml)のカプセル内に炭酸カルシウム粉末を60mg封入した。投与装置は、図10に示すシングルノズル型で実験した結果を表1に、また、図11に示す二つのノズル2a及び2bを持つダブルノズル型で実験した結果を表2に示す。穿孔針4の先端部の管部外径が1.25mm、軸管部の外径が0.9mmであり、カプセルKに穿孔された開口の辺縁と、中軸部分との間隙幅が、0.175mmであった。ここでは、ポンピングにより窄まった押圧ポンプ14a内に外気を吸引させるために、吸気弁10aを設けた。
[Experimental Example 1]
The capsule was loaded into the dosing device, and the ejection rate was measured by the number of pumping pumps.
In this experiment, 60 mg of calcium carbonate powder was sealed in a No. 2 size (capacity 0.37 ml) capsule. Table 1 shows the results of the experiment conducted with the single nozzle type shown in FIG. 10, and Table 2 shows the results of the experiment conducted with the double nozzle type having the two nozzles 2a and 2b shown in FIG. The outer diameter of the tube portion at the tip of the piercing needle 4 is 1.25 mm, the outer diameter of the shaft tube portion is 0.9 mm, and the gap width between the edge of the opening drilled in the capsule K and the middle shaft portion is 0. .175 mm. Here, the intake valve 10a is provided in order to suck the outside air into the pressure pump 14a which is narrowed by the pumping.

表1及び表2に示すように、本発明によると1回目のポンピングで90%以上のカプセル内の粉薬を噴出することが可能であり、投与装置内に漏れ出した粉薬は全く認められなかった。   As shown in Tables 1 and 2, according to the present invention, 90% or more of the powder in the capsule can be ejected by the first pumping, and no powder was leaked into the administration device. .

Figure 0005141881
Figure 0005141881

Figure 0005141881
Figure 0005141881

尚、シングルノズル型は、片方の鼻腔が鼻づまりを起こしたり鼻水が出る場合に、他方の鼻腔に選択的に投与することができる。また、ノズル部分を変更するだけで、ダブルノズル型投与装置にすることが可能である。   The single nozzle type can be selectively administered to the other nasal cavity when one of the nasal cavity causes a nasal congestion or runny nose. Moreover, it is possible to make a double-nozzle administration device only by changing the nozzle portion.

本発明に係る鼻腔内投薬装置の一実施例を示す縦断面図である。It is a longitudinal cross-sectional view which shows one Example of the intranasal medication apparatus which concerns on this invention. 本発明に係る鼻腔内投薬装置の一実施例を示す縦断面図である。It is a longitudinal cross-sectional view which shows one Example of the intranasal medication apparatus which concerns on this invention. 本発明に係る鼻腔内投薬装置の一実施例を示す縦断面図である。It is a longitudinal cross-sectional view which shows one Example of the intranasal medication apparatus which concerns on this invention. 本発明に係る鼻腔内投薬装置の要部分解斜視図である。It is a principal part disassembled perspective view of the intranasal medication apparatus concerning this invention. (a)は穿孔針の他の実施例を示す縦断面図、(b)は穿孔の横断面図である。(A) is the longitudinal cross-sectional view which shows the other Example of a piercing needle, (b) is a cross-sectional view of a piercing | piercing. (a)は穿孔針の他の実施例を示す縦断面図、(b)は穿孔の横断面図である。(A) is the longitudinal cross-sectional view which shows the other Example of a piercing needle, (b) is a cross-sectional view of a piercing | piercing. (a)は穿孔針の他の実施例を示す縦断面図、(b)は穿孔の横断面図である。(A) is the longitudinal cross-sectional view which shows the other Example of a piercing needle, (b) is a cross-sectional view of a piercing | piercing. (a)は穿孔針の他の実施例を示す縦断面図、(b)は穿孔の横断面図である。(A) is the longitudinal cross-sectional view which shows the other Example of a piercing needle, (b) is a cross-sectional view of a piercing | piercing. 穿孔パターンを示す要部縦断面図である。It is a principal part longitudinal cross-sectional view which shows a drilling pattern. 押圧ポンプ部の他の実施例を示す縦断面図である。It is a longitudinal cross-sectional view which shows the other Example of a press pump part. 押圧ポンプ部及び噴出ノズルの他の実施例を示す縦断面図である。It is a longitudinal cross-sectional view which shows the other Example of a press pump part and a jet nozzle.

符号の説明Explanation of symbols

1 キャップ
2 噴出ノズル
2a 噴出ノズル
2b 噴出ノズル
3 噴気路
4 穿孔部材(穿孔針)
4a 穿孔部材の先端管部
4b 穿孔部材の軸管部
4c 穿孔部材の後端管部
4d 穿孔部材の隔壁
4e 穿孔部材の内管(又は単管)
4f 穿孔部材の外管(又は単管)
4g 穿孔部材の溝条
4h 穿孔部材の棒体
5 送気路
5a 給気路
5b 排気路
6 カプセル収容部
7 薬剤
8 カプセルホルダー
8a 送気路
8b 凹所
9 第2可動弁
10 第1可動弁
10a第1可動弁の通気孔
10b第1可動弁の鍔部
11 カプセルホルダーと押圧ポンプの連結部材
11a連結部材の通気孔
11b気室
12 吸気路
13 端部隔壁
14 押圧ポンプ
14a押圧ポンプ
15 連結部材の空気流入口
16 外気
K カプセル
H1 給排気孔
Z 間隙
DESCRIPTION OF SYMBOLS 1 Cap 2 Ejection nozzle 2a Ejection nozzle 2b Ejection nozzle 3 Fumarole path 4 Perforation member (perforation needle)
4a Front tube portion 4b of the piercing member 4b Shaft tube portion 4c of the piercing member 4d rear end tube portion 4d Partition wall 4e of the piercing member Inner tube (or single tube) of the piercing member
4f Outer tube (or single tube) of perforated member
4g Groove 4h of piercing member Rod body 5 of piercing member 5 Air supply path 5a Air supply path 5b Exhaust path 6 Capsule accommodating portion 7 Drug 8 Capsule holder 8a Air supply path 8b Recess 9 Second movable valve 10 First movable valve 10a 1st movable valve vent 10b 1st movable valve collar 11 Capsule holder and press pump connecting member 11a connecting member 11a connecting member vent hole 11b air chamber 12 inlet passage 13 end partition 14 press pump 14a press pump 15 connecting member Air inlet 16 Outside air K Capsule H1 Supply / exhaust hole Z Gap

Claims (7)

鼻腔内に挿入可能に形成された噴出ノズルと、粉末状又は液体状の薬剤が封入されたカプセルが装填されるカプセル収容部と、該カプセル収納部に連通されると共に、カプセル内に空気を噴気する押圧ポンプ部と、前記カプセル内に空気が出入り可能な給排気孔を形成する穿孔部材とを備えた鼻腔内投薬装置において、前記噴出ノズル側のみに前記穿孔部材を設けると共に、押圧ポンプ部から送気される空気を噴出ノズル側のみに流通させる通気路を設け、前記穿孔部材が、管状に形成されると共に、その先端部管径が軸部管径よりも大に形成されていることを特徴とする鼻腔内投薬装置。 An ejection nozzle formed so as to be insertable into the nasal cavity, a capsule housing portion filled with a capsule filled with a powdery or liquid medicine, communicated with the capsule housing portion, and air is blown into the capsule In the intranasal medication device comprising a pressing pump unit that performs and a perforating member that forms an air supply / exhaust hole through which air can enter and exit from the capsule, the perforating member is provided only on the ejection nozzle side, and from the press pump unit An air passage is provided for circulating the air to be fed only to the ejection nozzle side , and the perforated member is formed in a tubular shape, and its tip end pipe diameter is formed larger than the shaft pipe diameter. Intranasal dosing device characterized. 穿孔部材を、カプセルへの空気流入口と薬剤が噴出される薬剤噴出口が単一の孔になるように形成可能に構成したこと特徴とする請求項1記載の鼻腔内投薬装置。 2. The intranasal administration device according to claim 1, wherein the piercing member is configured so that the air inlet to the capsule and the medicine outlet from which the medicine is ejected become a single hole. 穿孔部材が、内管と外管の二重のコアキシャル様に形成されていることを特徴とする請求項1又は請求項2記載の鼻腔内投薬装置。 The intranasal administration device according to claim 1 or 2, wherein the perforating member is formed in a double coaxial manner of an inner tube and an outer tube . 穿孔部材の内部が、二本の通路(ダブルルーメン様)に区画形成されていることを特徴とする請求項1又は請求項2記載の鼻腔内投薬装置。 The intranasal administration device according to claim 1 or 2 , wherein the inside of the piercing member is divided into two passages (double lumen-like) . 穿孔部材の外側面に、空気の噴出方向に倣って溝条が形成されていることを特徴とする請求項1又は請求項2記載の鼻腔内投薬装置。 The intranasal medication device according to claim 1 or 2, wherein a groove is formed on the outer surface of the piercing member along the direction of air ejection . 穿孔部材が少なくとも二本の管体から構成されていることを特徴とする請求項1記載の鼻腔内投薬装置。 2. The intranasal administration device according to claim 1, wherein the piercing member is composed of at least two tubes . 穿孔部材が少なくとも一対の棒体から構成され、一方の棒体の先端部軸径が軸部径よりも大に形成され、他方の棒体が直管状であることを特徴とする請求項1記載の鼻腔内投薬装置。 Piercing member is composed of at least a pair of rods, claim 1 tip shaft diameter of one of the rods is formed larger than the shaft portion diameter, the other rod is characterized straight tubular der Rukoto The intranasal dosing device as described.
JP2007331207A 2007-12-22 2007-12-22 Intranasal medication device Expired - Fee Related JP5141881B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007331207A JP5141881B2 (en) 2007-12-22 2007-12-22 Intranasal medication device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007331207A JP5141881B2 (en) 2007-12-22 2007-12-22 Intranasal medication device

Publications (2)

Publication Number Publication Date
JP2009148506A JP2009148506A (en) 2009-07-09
JP5141881B2 true JP5141881B2 (en) 2013-02-13

Family

ID=40918392

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007331207A Expired - Fee Related JP5141881B2 (en) 2007-12-22 2007-12-22 Intranasal medication device

Country Status (1)

Country Link
JP (1) JP5141881B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD755367S1 (en) 2014-03-10 2016-05-03 Civitas Therapeutics, Inc. Indicator for an inhaler
USD752734S1 (en) 2014-03-10 2016-03-29 Civitas Therapeutics, Inc. Inhaler grip
USD752204S1 (en) 2014-03-10 2016-03-22 Civitas Therapeutics, Inc. Indicator for an inhaler

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK479189D0 (en) * 1989-01-06 1989-09-28 Hans Gernot Schenk INHALER

Also Published As

Publication number Publication date
JP2009148506A (en) 2009-07-09

Similar Documents

Publication Publication Date Title
KR100187737B1 (en) Intranasal medicator
KR0173552B1 (en) Intranasal medicator
KR100234611B1 (en) Medicine administering device for nasal cavities
US8360057B2 (en) Medication inhaler for dispensing multiple capsules
US8464712B2 (en) Medication inhaler
KR101036150B1 (en) Powdery medicine dispensing device for nasal cavity
KR100974482B1 (en) Powder medicine applicator for nasal cavity
EP0745401A2 (en) Inhaler type medicine administering device
KR20050007536A (en) Powder chemical feeding device for nasal cavity
JP2006081917A (en) Dispenser
JP5141881B2 (en) Intranasal medication device
JP2012533082A (en) Droplet discharge device
JPH08322934A (en) Dosing device for nasal cavity
JP4963084B2 (en) Suction dispenser
JP2014180664A (en) Drug dispenser
JPH09276405A (en) Administrator for nasal cavity
JP3308419B2 (en) Nasal administration device
JPH08243164A (en) Medicating device for nostril
CN110913824B (en) Dissolving system during use
KR102144192B1 (en) Medical drug supply device having air removal element
JPH09140791A (en) Medicator
JP3308418B2 (en) Nasal administration device
JP3320265B2 (en) Nasal administration device
JPH0928805A (en) Nasal medicator
JP5415341B2 (en) Powder inhalation device

Legal Events

Date Code Title Description
A625 Written request for application examination (by other person)

Free format text: JAPANESE INTERMEDIATE CODE: A625

Effective date: 20101216

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110127

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20120627

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120717

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20120914

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20120914

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120918

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120914

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121030

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121106

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20151130

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees